At ISNTD d³ 2017, Dr. Benny Baeten, Compound Development Team Leader Anthelmintics at Janssen Pharmaceutica (a J&J Global Health company) speaks about J&J's commitment to delivering the pledges of the 2012 London Declaration on NTDs, including current developments in antihelminthics research and partnerships.
…………………………………………………….
For more information please contact:
Kamran Rafiq
#NTDs #JohnsonJohnson #lymphaticfilariasis #drugdiscovery #STH #onchocerciasis #flubendazole #ivermectin